Research

Get Involved in CAMK2 Research Pan M, Liu PW, Ozawa Y, Arima-Yoshida F, Dong G, Sawahata M, Mori D, Nagase M, Fujii H, Ueda S, Yabuuchi Y, Liu X, Narita H, Konno A, Hirai H, Ozaki N, Yamada K, Kidokoro H, Bito H, Mizoguchi H, Watabe M, Horigane SI, Takemoto-Kimura S. A hyper-activatable CAMK2A variant associated with intellectual disability causes exaggerated long-term potentiation and learning impairments. Transl Psychiatry. 2025 Mar 26;15(1):95. doi: 10.1038/s41398-025-03316-4. PMID: 40140673; PMCID: PMC11947108. CAMK2 Research Grants Advancing meaningful therapies for individuals affected by CAMK2-related disorders requires a strong commitment to high-quality, impactful research. One of the core missions of the CAMK2 Therapeutics Network is to identify, support, and fund scientific projects that have the greatest potential to improve our understanding of CAMK2 biology, address unmet needs within the community, and accelerate the development of future treatments. CAMK2 Strategic Research Roadmap In July 2025, the CAMK2 Therapeutics Network brought together families, clinicians, researchers, and scientific leaders from around the world to develop the first comprehensive strategic research roadmap for CAMK2-related disorders. Guided by the priorities of the community and informed by leading experts in CAMK2 biology, neurodevelopmental disorders, and therapeutic development, participants worked together to identify the most important challenges, opportunities, and research needs facing the field. Current Studies